BACKGROUND: Heterozygous human mutations of NKX2-5 are highly penetrant and associated with varied congenital heart defects. The heterozygous knockout of murine Nkx2-5, in contrast, manifests less profound cardiac malformations, with low disease penetrance. We sought to study this apparent discrepancy between human and mouse genetics. Because missense mutations in the NKX2-5 homeodomain (DNA-binding domain) are the most frequently reported type of human mutation, we replicated this genetic defect in a murine knockin model. METHODS AND RESULTS: We generated a murine model in a 129/Sv genetic background by knocking-in an Nkx2-5 homeodomain missense mutation previously identified in humans. The mutation was located at homeodomain position 52Arg→Gly (R52G). All the heterozygous neonatal Nkx2-5(+/R52G) mice demonstrated a prominent trabecular layer in the ventricular wall, so called noncompaction, along with diverse cardiac anomalies, including atrioventricular septal defects, Ebstein malformation of the tricuspid valve, and perimembranous and muscular ventricular septal defects. In addition, P10 Nkx2-5(+/R52G) mice demonstrated atrial sepal anomalies, with significant increase in the size of the interatrial communication and fossa ovalis, and decrease in the length of the flap valve compared with control Nkx2-5(+/+) or Nkx2-5(+/-) mice. CONCLUSIONS: The results of our study demonstrate that heterozygous missense mutation in the murine Nkx2-5 homeodomain (R52G) is highly penetrant and result in pleiotropic cardiac effects. Thus, in contrast to heterozygous Nkx2-5 knockout mice, the effects of the heterozygous knockin mimic findings in humans with heterozygous missense mutation in NKX2-5 homeodomain.
BACKGROUND: Heterozygous human mutations of NKX2-5 are highly penetrant and associated with varied congenital heart defects. The heterozygous knockout of murineNkx2-5, in contrast, manifests less profound cardiac malformations, with low disease penetrance. We sought to study this apparent discrepancy between human and mouse genetics. Because missense mutations in the NKX2-5 homeodomain (DNA-binding domain) are the most frequently reported type of human mutation, we replicated this genetic defect in a murine knockin model. METHODS AND RESULTS: We generated a murine model in a 129/Sv genetic background by knocking-in an Nkx2-5 homeodomain missense mutation previously identified in humans. The mutation was located at homeodomain position 52Arg→Gly (R52G). All the heterozygous neonatal Nkx2-5(+/R52G) mice demonstrated a prominent trabecular layer in the ventricular wall, so called noncompaction, along with diverse cardiac anomalies, including atrioventricular septal defects, Ebstein malformation of the tricuspid valve, and perimembranous and muscular ventricular septal defects. In addition, P10Nkx2-5(+/R52G) mice demonstrated atrial sepal anomalies, with significant increase in the size of the interatrial communication and fossa ovalis, and decrease in the length of the flap valve compared with control Nkx2-5(+/+) or Nkx2-5(+/-) mice. CONCLUSIONS: The results of our study demonstrate that heterozygous missense mutation in the murineNkx2-5 homeodomain (R52G) is highly penetrant and result in pleiotropic cardiac effects. Thus, in contrast to heterozygous Nkx2-5 knockout mice, the effects of the heterozygous knockin mimic findings in humans with heterozygous missense mutation in NKX2-5 homeodomain.
Authors: Sonisha A Warren; Ryota Terada; Laura E Briggs; Colleen T Cole-Jeffrey; Wei-Ming Chien; Tsugio Seki; Ellen O Weinberg; Thomas P Yang; Michael T Chin; Jörg Bungert; Hideko Kasahara Journal: Mol Cell Biol Date: 2011-09-19 Impact factor: 4.272
Authors: Ryota Terada; Sonisha Warren; Jonathan T Lu; Kenneth R Chien; Andy Wessels; Hideko Kasahara Journal: Cardiovasc Res Date: 2011-02-01 Impact factor: 10.787
Authors: Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder Journal: Nat Rev Cardiol Date: 2010-11-02 Impact factor: 32.419
Authors: D W Benson; G M Silberbach; A Kavanaugh-McHugh; C Cottrill; Y Zhang; S Riggs; O Smalls; M C Johnson; M S Watson; J G Seidman; C E Seidman; J Plowden; J D Kugler Journal: J Clin Invest Date: 1999-12 Impact factor: 14.808
Authors: Frederik J de Lange; Antoon F M Moorman; Robert H Anderson; Jörg Männer; Alexandre T Soufan; Corrie de Gier-de Vries; Michael D Schneider; Sandra Webb; Maurice J B van den Hoff; Vincent M Christoffels Journal: Circ Res Date: 2004-08-05 Impact factor: 17.367
Authors: Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell Journal: Circulation Date: 2018-11-20 Impact factor: 29.690
Authors: Milena B Furtado; Julia C Wilmanns; Anjana Chandran; Joelle Perera; Olivia Hon; Christine Biben; Taylor J Willow; Hieu T Nim; Gurpreet Kaur; Stephanie Simonds; Qizhu Wu; David Willians; Ekaterina Salimova; Nicolas Plachta; James M Denegre; Stephen A Murray; Diane Fatkin; Michael Cowley; James T Pearson; David Kaye; Mirana Ramialison; Richard P Harvey; Nadia A Rosenthal; Mauro W Costa Journal: JCI Insight Date: 2017-03-23
Authors: Daniel M DeLaughter; Alexander G Bick; Hiroko Wakimoto; David McKean; Joshua M Gorham; Irfan S Kathiriya; John T Hinson; Jason Homsy; Jesse Gray; William Pu; Benoit G Bruneau; J G Seidman; Christine E Seidman Journal: Dev Cell Date: 2016-11-10 Impact factor: 12.270